.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

SURFAXIN Drug Profile

« Back to Dashboard
Surfaxin is a drug marketed by Discovery Labs and is included in one NDA. It is available from one supplier.

The generic ingredient in SURFAXIN is lucinactant. One supplier is listed for this compound. Additional details are available on the lucinactant profile page.

Summary for Tradename: SURFAXIN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1

Clinical Trials for: SURFAXIN

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Discovery Labs
SURFAXIN
lucinactant
SUSPENSION;INTRATRACHEAL021746-001Mar 6, 2012DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SURFAXIN

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Discovery Labs
SURFAXIN
lucinactant
SUSPENSION;INTRATRACHEAL021746-001Mar 6, 20125,407,914<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc